ARCHIVES

Assembly of Scientists, started as a result of conflict of interest controversy, plans Sept. 14 meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Concept For New Cytogenetics RFA

August 3, 1984

Blood Cancers Advocacy Groups Seek DOD And NCI Funds, Medicare Coverage.

July 6, 2001

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

HHS Inquiry Triggers Sloppy Stories On Gallo’s Laboratory

July 21, 1989

BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It

April 8, 1983